Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

28 terminated/withdrawn out of 140 trials

Success Rate

72.5%

-14.0% vs industry average

Late-Stage Pipeline

20%

28 trials in Phase 3/4

Results Transparency

72%

53 of 74 completed trials have results

Key Signals

19 recruiting53 with results21 terminated7 withdrawn

Enrollment Performance

Analytics

N/A

80(68.4%)

Phase 4

18(15.4%)

Phase 3

10(8.5%)

Phase 1

6(5.1%)

Phase 2

2(1.7%)

Early Phase 1

1(0.9%)

117Total

N/A(80)

Phase 4(18)

Phase 3(10)

Phase 1(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (140)

Showing 20 of 140 trials

NCT07727057Not ApplicableRecruiting

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Ventricular Arrhythmias

Role: lead

NCT07523750Not ApplicableRecruiting

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

Role: lead

NCT07527299Not ApplicableRecruiting

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Role: lead

NCT07227532Not ApplicableRecruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Role: lead

NCT07116525Not ApplicableRecruiting

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

Role: lead

NCT07429214Not ApplicableRecruiting

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

Role: lead

NCT04088071Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Role: collaborator

NCT07428564Not ApplicableRecruiting

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE PRO Software in Participants With PsAF

Role: lead

NCT05565599Not ApplicableActive Not Recruiting

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Role: lead

NCT03963349Active Not Recruiting

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study

Role: lead

NCT06168942Not ApplicableSuspended

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

Role: lead

NCT04750798Recruiting

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

Role: lead

NCT02565069Not ApplicableCompleted

Identification for the Treatment of Complex Arrhythmias

Role: lead

NCT05685134Not ApplicableCompleted

Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome

Role: collaborator

NCT04282850Not ApplicableTerminated

Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

Role: collaborator

NCT05971693Not ApplicableCompleted

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator

Role: lead

NCT06455098Not ApplicableRecruiting

A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

Role: lead

NCT07362134Not ApplicableEnrolling By Invitation

Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter

Role: collaborator

NCT04239144Not ApplicableCompleted

Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease

Role: collaborator

NCT07363278Recruiting

A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System

Role: collaborator